Patents Assigned to Ivax Laboratories, Inc.
  • Glucuronic acid derivatives of opioid antagonists
    Patent number: 4774230
    Abstract: Intestine-specific delivery of an opioid antagonist can be accomplished without substantial central nervous system effects by administering the antagonist orally in the form of the glucuronide derivative.
    Type: Grant
    Filed: March 26, 1988
    Date of Patent: September 27, 1988
    Assignee: Ivax Laboratories, Inc.
    Inventors: Ronald R. Tuttle, Ross Dixon, Maciej M. Smulkowski